ARDS Stem Cell Treatment: 300 Million IV + Nebulized MSCs at Dream Body Clinic
ARDS stem cell treatment at Dream Body Clinic is a multi-modal protocol that combines a 300 million mesenchymal stem cell (MSC) intravenous infusion with four nebulized sessions of 25 million MSCs each to support lung inflammation reduction and alveolar repair. The all-inclusive package is $18,000 USD and includes spirometry, chest CT, bloodwork, NAD+ and high-dose vitamin C IV, and physician review.
The cells are allogeneic MSCs derived from Wharton’s jelly and placenta, expanded on site in the clinic’s ISO-rated lab. Patients plan a minimum seven-day stay in BucerÃas / Nuevo Vallarta. Treatment is administered after imaging and laboratory clearance by the clinic’s internist. Results vary, and the clinic does not treat patients with cancer in the past five years.
A free consultation is available to review candidacy and current availability. Call (888) 704-3977 or email info@dreambodyclinic.net.
ACUTE RESPIRATORY DISTRESS SYNDROME
ARDS Stem Cell Treatment
Revolutionary multi-modal protocol combining IV + Nebulized MSCs to reduce mortality, repair alveoli, and restore lung function
$18,000 USD
All-Inclusive Price
7 Days
Minimum Stay
300M + 4×25M
IV + Nebulized MSCs
The ARDS Stem Cell Treatment Consists of the Following:
Spirometry & Chest CT
Full pulmonary function test and chest CT scan, then analysis with our internist to establish baseline and clear you for treatment.
300 Million Stem Cell IV
Our highest-dose MSC IV — 300 million Wharton’s Jelly-derived mesenchymal stem cells infused directly into the bloodstream to reach the lungs systemically.
4 Sessions of 25M MSCs via Nebulizer
25 million MSCs delivered directly into the lungs via nebulizer in 4 targeted sessions — maximising local lung tissue repair alongside the systemic IV dose.
NAD+ & High Dose Vitamin C IV
Administered after the stem cell IV to reduce oxidative stress, support cellular energy production, and amplify the regenerative response.
7-Day Treatment Schedule
Patients must be in Bucerias or Nuevo Vallarta for at least 7 days. Select accommodations nearby as this protocol requires frequent clinic visits.
1
Arrive and Rest
Check in to your hotel in Bucerias or Nuevo Vallarta. Rest and recover from travel.
2
Bloodwork, Spirometry & Chest CT
Full blood panel, pulmonary function test, and chest CT scan completed at the clinic.
3
Review Scans with Internist
Our internist reviews all scans to clear you for treatment. They reserve the right to deny treatment if your body cannot safely handle it.
4
Free Day — Cell Preparation
We take the MSCs out of cultivation this day to prepare them for your treatment tomorrow.
5
IV Stem Cell Treatment + 2nd Nebulized Session
Receive your 300M Stem Cell IV plus the first and second nebulized MSC sessions.
6
Two Nebulized Sessions
Two nebulized MSC sessions — one in the morning and one in the afternoon — for maximum local lung delivery.
7
Fly Home
Morning rest and final check-in. Transportation to PVR airport provided. We recommend staying one additional day to rest if possible.
Important
If you are in town for more than 7 days, sessions may not be on consecutive days. Always stay in Bucerias or Nuevo Vallarta for easy transportation.
The ARDS Stem Cell Treatment at Dream Body Clinic
Looking for a revolutionary way to treat Acute Respiratory Distress Syndrome (ARDS)? With our advanced ARDS stem cell treatment, we can help reduce inflammation, promote tissue repair, and improve lung function. Our treatment is based on the use of mesenchymal stem cells, which have shown incredible results in reducing mortality rates associated with ARDS.
At Dream Body Clinic, we understand that ARDS can be a life-threatening condition that requires rapid intervention. That’s why our team of experienced medical professionals is dedicated to providing prompt, effective, and scientifically proven treatment options.
We use Wharton’s Jelly (umbilical cord tissue) and placenta to derive our pure, isolated MSCs. Then we cultivate them to get the hundreds of millions necessary for this advanced treatment. The MSCs are then safely infused into your body to facilitate natural healing and regeneration. MSCs also release growth factors and cytokines that promote tissue regeneration, reduce inflammation, and modulate the immune response — all of which are crucial for pulmonary health.
Our treatment is minimally invasive, requires little or no downtime, and is accompanied by minimal discomfort.
Call (888) 704-3977 For a Free Consultation
You can also email us at info@dreambodyclinic.net
ARDS Stem Cell Treatment at Dream Body Clinic
Reduce inflammation, repair alveolar tissue, and improve lung function. Call (888) 704-3977 or info@dreambodyclinic.net
How Mesenchymal Stem Cells Work for ARDS
Three powerful anti-inflammatory molecules released by MSCs that drive lung repair
How MSCs Work for ARDS
When injected intravenously, MSCs reach the lungs and act on various cell types involved in the inflammation response. MSCs secrete anti-inflammatory cytokines and growth factors, reducing inflammation, promoting tissue regeneration, and repairing damaged alveoli. MSCs also have a paracrine effect — signalling neighbouring cells to promote tissue regeneration and keep lung tissue healthy.
How MSCs Help Alveoli in ARDS
MSCs secrete anti-inflammatory molecules including interleukin-10, TGF-beta, and prostaglandin E2, which reduce inflammation and improve alveolar gas exchange. MSCs can also differentiate into type II pneumocytes — cells responsible for producing surfactant, which reduces surface tension in the alveoli and prevents collapse during exhalation.
Interleukin-10 (IL-10) Released by MSCs
IL-10 is a potent anti-inflammatory cytokine released by MSCs that inhibits the activity of pro-inflammatory cytokines such as TNF-alpha, IL-1, and IL-6. By inhibiting these cytokines, IL-10 reduces lung inflammation, reduces damage to alveolar tissue, and prevents further loss of lung function.
In addition to anti-inflammatory effects, IL-10 promotes tissue repair by stimulating the growth and differentiation of type II pneumocytes, which produce surfactant — a vital component that maintains structural integrity and prevents alveolar collapse.
Transforming Growth Factor-Beta (TGF-β)
TGF-beta plays a crucial role in modulating inflammation and triggering tissue regeneration. When MSCs are introduced into the bloodstream, they release TGF-beta, which promotes the proliferation of fibroblasts, endothelial cells, and epithelial cells involved in tissue repair.
TGF-beta also stimulates VEGF secretion, helping stimulate blood vessel formation and angiogenesis — promoting neovascularisation and aiding in tissue repair throughout the damaged lung architecture.
Prostaglandin E2 (PGE2) Released by MSCs
PGE2 is a lipid mediator produced by MSCs that reduces inflammation by inhibiting TNF-alpha and IL-6, while increasing anti-inflammatory cytokines and enhancing phagocytosis. PGE2 also promotes tissue repair by regulating lung cell proliferation and stimulating endothelial growth for new blood vessel formation.
Furthermore, PGE2 has immunomodulatory properties that maintain a healthy balance between pro- and anti-inflammatory processes — preventing excessive inflammation while enabling healing.
ARDS Mesenchymal Stem Cell Studies
- Mesenchymal stem cells: current clinical progress in ARDS and COVID-19
- Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis
- Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial
- Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series
- Mesenchymal stem cells-derived extracellular vesicles in ARDS: a review of current literature
- Mesenchymal stem cell therapy for severe COVID-19 ARDS
- Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which MSCs Enhance Macrophage Phagocytosis in In Vitro and In Vivo Models of ARDS
Side Effects & Risks
- 1 in 100 people may experience a slight fever and/or headache for a few hours after treatment. 500mg of Tylenol easily resolves this.
- Any IV treatment carries a theoretical risk of infection. We have never had a patient experience an infection due to our sterility protocols.
- We do not treat patients who have had cancer within the past 5 years.
- As with any medical treatment there is no guarantee of results, but our outcomes have been excellent for the vast majority of patients.
- There is a risk of releasing a thrombus from the veins in all IV patients, especially those with high cholesterol. Bloodwork on Day 2 minimises this risk. Our lab has over 8 years of cultivating MSCs with perfect safety.
How Long Do Results Last?
The results from the ARDS stem cell treatment can last for years or even indefinitely. Any improvement to your lung tissue will last because it is new pulmonary tissue. The stem cells will also reprogram your immune system to work the way it was designed to work. Once immune cells are reprogrammed and lung damage is repaired, things will work as they should — this is real regeneration, not symptom masking.
MSCs administered via IV stay in the system for 8–12 months. During that time they interact with immune cells, seek out inflammation, and guide cellular regeneration.
9 Things to Know Before Getting Stem Cell ARDS Treatment in Mexico
Lasting lung damage after acute respiratory distress syndrome (ARDS) can leave people short of breath and limited in daily life. If you are exploring a regenerative option, here are nine things to know before you book stem cell ARDS treatment at Dream Body Clinic in BucerÃas, near Puerto Vallarta.
1. The protocol combines an IV with nebulized cells
The treatment is a multi-modal protocol: a 300 million mesenchymal stem cell (MSC) IV, plus four nebulized sessions of 25 million MSCs each (100 million by nebulizer), delivered directly into the lungs. A NAD+ and high-dose vitamin C IV follows the stem cell IV. The aim is to help reduce lung inflammation and support alveolar repair. The page describes the 300 million IV as the clinic’s highest-dose MSC IV.
2. The cells are made in the clinic’s own lab
The cells are allogeneic MSCs derived from Wharton’s jelly and placenta and expanded on site in the clinic’s ISO-rated lab. The clinic says its lab has more than 8 years of experience cultivating MSCs.
3. There is one published price
The all-inclusive package is $18,000 USD. It includes spirometry, a chest CT, bloodwork, the 300 million cell IV, the four nebulized sessions, the NAD+ and high-dose vitamin C IV, and physician review.
4. The cells work by signaling
MSCs release anti-inflammatory molecules, including interleukin-10, TGF-beta and prostaglandin E2, and signal neighboring cells in a paracrine effect. The page says these effects aim to reduce inflammation and support repair of damaged lung tissue and gas exchange. The clinic states that results vary, that there is no guarantee, and that the therapy is not promoted as a cure.
5. A specialist screens you before any treatment
Your first days include a full blood panel, a pulmonary function test (spirometry) and a chest CT. The clinic’s internist reviews them to establish your baseline and clear you for treatment. The internist reserves the right to deny treatment if your body can’t safely handle it.
6. It is not right for everyone
The clinic does not treat anyone who has had cancer in the past 5 years, as a precaution. Treatment depends on imaging and lab clearance. Any IV treatment carries a small risk of infection and of releasing a clot (thrombus) from the veins, especially in people with high cholesterol, which is why bloodwork comes first. About 1 in 100 people may have a slight fever or headache for a few hours afterward. Acute, life-threatening respiratory distress needs hospital care, so ask your pulmonologist whether an outpatient protocol is suitable for you.
7. Plan for at least seven days in town
This is a longer stay than most of the clinic’s treatments, and the clinic asks you to stay in BucerÃas or Nuevo Vallarta because it needs frequent clinic visits. Day 1 arrive and rest, Day 2 bloodwork, spirometry and chest CT, Day 3 internist review, Day 4 free day while the cells are prepared, Day 5 IV plus nebulized sessions, Day 6 two nebulized sessions, Day 7 fly home. Airport transport to Puerto Vallarta (PVR) is provided, and the clinic suggests an extra day of rest if possible.
8. Recovery and results are gradual
The page describes the treatment as minimally invasive with little or no downtime. The cells are described as staying in the system for about 8 to 12 months while they interact with immune cells and seek out inflammation. Results vary and are not guaranteed, so set a baseline with your own pulmonologist and track breathing tests over time.
9. Prepare before you come
- Bring recent imaging, lung function tests and your medication list.
- Tell the clinic about cancer history, cholesterol or clotting history, blood thinners, infection and implanted devices.
- Book lodging in BucerÃas or Nuevo Vallarta for the whole stay.
- Keep your own pulmonologist informed and involved in follow-up.
Always check with your own doctor before changing any prescribed medication.
Ready to find out if you’re a candidate? Call (888) 704-3977, WhatsApp +52 322 232 1055, or email info@dreambodyclinic.net for a free consultation.
Results vary. This content is for education and is not medical advice. This is a clinic protocol, not an FDA-approved U.S. indication.
Considering stem cell treatment for ARDS in Mexico? Learn the 300M IV plus nebulized MSC protocol, what’s included, who qualifies and more at:Â https://dreambody.clinic/ards-stem-cell-treatment/
How to Get the ARDS Stem Cell Treatment
Ready to restore your respiratory health? Call (888) 704-3977 or click the button below to learn how to book. Email us at info@dreambodyclinic.net
Reviewed by the treating physician
Dr. Arick Francisco Barba Lopez
Head Physician
Dream Body Clinic, Bucerias, Mexico
- Graduate, Universidad Autónoma de Guadalajara
- Graduate certificate in regenerative medicine
- About 10 years administering mesenchymal stem cell therapies
- Honoris Causa, UNCEMA, 2021
- Reviews this page for protocol, dose, and candidacy accuracy
Content last reviewed September 26, 2026 · Next scheduled review March 2027
This page describes a clinic protocol, not an FDA-approved U.S. indication.